Table 4.

Comparison of outcomes between the HEPA and non-HEPA groups.

	Estimator	Univariate analysis		Multivariate analysis
		Crude estimator (95% CI)	P value	Adjusted estimatora (95% CI)	P value
100-day mortality	HR	1.39 (0.44–4.37)	0.576	1.65 (0.52–5.23)	0.399
All-cause mortality	HR	0.90 (0.72–1.13)	0.370	0.92 (0.74–1.16)	0.483
Length of stay for treatment course of ASCT ≥ median (23 days)	OR	1.97 (1.52–2.55)	< 0.001	1.50 (1.14–1.98)	0.004
Emergency room visits within 14 days	OR	1.32 (0.81–2.15)	0.264	1.39 (0.85–2.30)	0.194
Readmission within 14 days	OR	1.59 (0.89–2.83)	0.114	1.20 (0.64–2.25)	0.561

OR odds ratio; HR hazards ratio; CI confidence interval.

^aAdjusted factors with p < 0.1 in the univariate analysis were included in the multivariate analysis.